CLINICAL_TRIALS
trial_result
· 2015-01-16
Clinical Trial Update: Phase 3 Papulopustular Rosacea Study [Phase 3]
Summary
Phase 3 trial for papulopustular rosacea has been completed; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Galderma R&D | Conditions: Papulopustular Rosacea (PPR) | Phase 3 | Status: COMPLETED | Results posted: 2015-01-16